MedTrace Logo

Impact of Antenatal Corticosteroid Therapy on Postnatal Surfactant Use in Preterm Infants

NCT05455879 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 145

Last updated 2024-09-19

No results posted yet for this study

Summary

No study has shown that two doses of corticosteroids are more effective than a single dose in lung maturation and prevention of hyaline membrane disease (HMD) The aim of this study is to assess the impact of the number of doses on the severity of HMD.

Conditions

  • Hyaline Membrane Disease (HMD)

Interventions

OTHER

Impact of antenatal corticosteroid therapy on surfactants use postnatal

Intervention Description: Retrospective study on preterm infants to evaluate the impact of antenatal corticosteroid therapy on surfactants use postnatal

Sponsors & Collaborators

  • Hôpital NOVO

    lead OTHER

Principal Investigators

  • Dr Suzanne BORRHOMEE · Hôpital NOVO

Eligibility

Max Age
37 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-20
Primary Completion
2022-07-05
Completion
2022-07-05

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05455879 on ClinicalTrials.gov